|
AGGF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.817700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.702100E-02 |
| Normal-vs-Stage2 |
4.785600E-01 |
| Normal-vs-Stage3 |
7.379600E-01 |
| Normal-vs-Stage4 |
1.870220E-02 |
| Stage1-vs-Stage2 |
7.632400E-01 |
| Stage1-vs-Stage3 |
4.531600E-01 |
| Stage1-vs-Stage4 |
5.323400E-01 |
| Stage2-vs-Stage3 |
7.766400E-01 |
| Stage2-vs-Stage4 |
4.221600E-01 |
| Stage3-vs-Stage4 |
3.373600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.579700E-02 |
| Normal-vs-AfricanAmerican |
2.388400E-01 |
| Normal-vs-Asian |
7.636200E-01 |
| Caucasian-vs-AfricanAmerican |
7.712200E-01 |
| Caucasian-vs-Asian |
3.732600E-01 |
| AfricanAmerican-vs-Asian |
4.308800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.104170E-02 |
| Normal-vs-Female |
8.461600E-01 |
| Male-vs-Female |
2.396400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.589700E-02 |
| Normal-vs-Extreme_Weight |
5.857900E-03 |
| Normal-vs-Obese |
3.695200E-01 |
| Normal-vs-Extreme_Obese |
3.588600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.251600E-01 |
| Normal_Weight-vs-Obese |
3.270400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.828800E-01 |
| Extreme_Weight-vs-Obese |
1.354950E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.559400E-01 |
| Obese-vs-Extreme_Obese |
6.541600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.355000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.246400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.439200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.842170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.605400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.165200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.361400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.464000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.348800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.273400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.615800E-02 |
| Normal-VS-Type2 PRCC |
2.049800E-01 |
| Normal-VS-KIRP CIMP |
1.241810E-02 |
| Normal-VS-Unclassified PRCC |
7.608800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.416400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.005000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.927630E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.786400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.670400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.118400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.898100E-02 |
| Normal-vs-N1 |
7.654000E-01 |
| Normal-vs-N2 |
2.451900E-02 |
| N0-vs-N1 |
2.004800E-01 |
| N0-vs-N2 |
7.247000E-01 |
| N1-vs-N2 |
3.506000E-01 |
|
|
